Cargando…
Pituitary Adenylate Cyclase-Activating Polypeptide Protects Glomerular Podocytes from Inflammatory Injuries
Diabetic nephropathy (DN) is a leading cause of end-stage kidney disease; however, there are few treatment options. Inflammation plays a crucial role in the initiation and/or progression of DN. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide, which was originally isolate...
Autores principales: | Sakamoto, Kenichi, Kuno, Kyoko, Takemoto, Minoru, He, Peng, Ishikawa, Takahiro, Onishi, Shunichiro, Ishibashi, Ryoichi, Okabe, Emiko, Shoji, Mayumi, Hattori, Akiko, Yamaga, Masaya, Kobayashi, Kazuki, Kawamura, Harukiyo, Tokuyama, Hirotake, Maezawa, Yoshiro, Yokote, Koutaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363873/ https://www.ncbi.nlm.nih.gov/pubmed/25821833 http://dx.doi.org/10.1155/2015/727152 |
Ejemplares similares
-
A novel podocyte gene, semaphorin 3G, protects glomerular podocyte from lipopolysaccharide-induced inflammation
por: Ishibashi, Ryoichi, et al.
Publicado: (2016) -
Sitagliptin Improves Postprandial Hyperglycemia by Inhibiting Glucagon Secretion in Werner Syndrome With Diabetes
por: Watanabe, Kaneyuki, et al.
Publicado: (2013) -
Sitagliptin Successfully Ameliorates Glycemic Control in Werner Syndrome With Diabetes
por: Kitamoto, Takumi, et al.
Publicado: (2012) -
Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes
por: Maezawa, Yoshiro, et al.
Publicado: (2015) -
Human glomerular transcriptome of diabetic kidneys: Can the podocyte cytoskeleton be a therapeutic target?
por: Maezawa, Yoshiro, et al.
Publicado: (2018)